Barclays Maintains Overweight on Celestica, Lowers Price Target to $406
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and lowers the price target from $430 to $406.
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and lowers the price target from $430 to $406.